[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 24, 1903


Author Affiliations


JAMA. 1903;XL(4):217-218. doi:10.1001/jama.1903.92490040013001b

It is generally conceded that the salicylates in some form constitute the most satisfactory remedy for acute rheumatism. These drugs are no longer considered a specific for rheumatism in the sense that quinin is a specific for malaria, but they have some very definite action with regard to the general symptom-complex known as acute articular rheumatism that makes the patient more comfortable than any other set of remedies. It is even allowable, in a certain sense, to use the expression that the employment of salicylates constitutes a therapeutic test for true rheumatism. The salicylates do not affect secondary infectious complications of joint structures, due either to the pus cocci, or to the influenza bacillus, or to the microbe of mumps or other such affections, nor to the arthritis that is due to the gonococcus. It is true they do not affect all cases of rheumatism favorably. But there is

First Page Preview View Large
First page PDF preview
First page PDF preview